FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/070496 [Registered on: 11/07/2024] Trial Registered Prospectively
Last Modified On: 10/07/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Physiotherapy (Not Including YOGA) 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Neuro-rehabilitation for improving Hand function in patients with Stroke 
Scientific Title of Study   Development and Testing of Neuro-Rehabilitation Strategies for improving Hand Functions beyond Brunnstrom Stage II in Stroke Patients 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Prachi Tiwari 
Designation  PhD Scholar 
Affiliation  Lovely Professional University 
Address  Department of Physiotherapy, School of Physiotherapy and Paramedical Sciences, Faculty of Applied Medical Sciences, Lovely Professional University,Phagwara, Punjab

Kapurthala
PUNJAB
144411
India 
Phone  9811644726  
Fax    
Email  prachitiwari005@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Suresh Mani 
Designation  Professor 
Affiliation  Lovely Professional University 
Address  Department of Physiotherapy, School of Physiotherapy and Paramedical Sciences, Faculty of Applied Medical Sciences, Lovely Professional University,Phagwara, Punjab

Kapurthala
PUNJAB
144411
India 
Phone  9878331006  
Fax    
Email  suresh.22315@lpu.co.in  
 
Details of Contact Person
Public Query
 
Name  Prachi Tiwari 
Designation  PhD Scholar 
Affiliation  Lovely Professional University 
Address  Department of Physiotherapy, School of Physiotherapy and Paramedical Sciences, Faculty of Applied Medical Sciences, Lovely Professional University,Phagwara, Punjab


PUNJAB
144411
India 
Phone  9811644726  
Fax    
Email  prachitiwari005@gmail.com  
 
Source of Monetary or Material Support  
Jamia Hamdard,Hamdard Nagar, New Delhi-110062, India 
 
Primary Sponsor  
Name  Nil 
Address  Nil 
Type of Sponsor  Other [Nil] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 2  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sunil Kohli  Jamia Hamdard  Department of Physiotherapy, Rehabilitation Center, Room No.-05, Hamdard Nagar, New Delhi-110062
South
DELHI 
9873351206

sunil.kohli@gmail.com 
Prachi Tiwari  Jamia Hamdard  Department of Physiotherapy,Rehabilitation Center, Room No.-05, Hamdard Nagar, New Delhi-110062
South
DELHI 
9811644726

prachitiwari005@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
Jamia Hamdard Institutional Ethical Committee  Approved 
Lovely Professional University  No Objection Certificate 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G460||Middle cerebral artery syndrome,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Conventional Physiotherapy   range of motion, stretching and strengthening exercises of Hand. The duration of the study will be 12 weeks as most of the improvement in hand function occurs in between 8 weeks to 32 weeks. The dosage will be 45 mins, 5 days per week, at 50-80 % of maximum Heart Rate. This 45 mins session will include 5-10 min of warm-up and cool-down.  
Intervention  Neurorehabilitation Strategies   1. Electrosomatosensory Stimulation of Median,Ulnar and Radial nerve 2. Mirror Therapy 3. MRP 4. NDT 5. Trunk Stability Exercises 6. Constrained Induced Movement Therapy The duration of the study will be 12 weeks as most of the improvement in hand function occurs in between 8 weeks to 32 weeks.The dosage will be 45 mins, 5 days per week, at 50-80 % of maximum Heart Rate. This 45 mins session will include 5-10 min of warm-up and cool-down. 
 
Inclusion Criteria  
Age From  45.00 Year(s)
Age To  55.00 Year(s)
Gender  Both 
Details  1. Patients with acute episode of stroke
2. Patient with Middle Cerebral Artery (MCA) involvement
3. Patients having haemorrhagic or non-haemorrhagic stroke
4. Patients who were in stage III in Brunnstrom hand recovery scale.
5. Mini mental State Examination Scale (MMSE) Score equal to or greater than 24
6. Patients who are able to understand and obeys command
 
 
ExclusionCriteria 
Details  1. Patients having a history of prior stroke involving other hemisphere
2. Patients having poor cognitive function and aphasia
3. Patients having visual ,hearing deficit and perceptual deficit
4. Patients having emotional changes such as emotional lability, indifference, euphoria, anosoagnosia
5. Patients having secondary deformation due to musculoskeletal disease in hand
6. Patient having musculoskeletal disorder affecting shoulder.
7. Pain with VAS score greater than 4
8. Patients having uncontrolled diabetes and hypertension.
9. Patient having any other neurological disorder except stroke Demyelinating and Degenerative diseases of brain such as myelopathy ,myopathy, traumatic head injury, intracranial tumour
10. Arthritis
11. Acute Respiratory Distress Syndrome
12. Patient with Myocardial Infaction ,stable angina
13. Patient having pacemaker or any other metal implant in body
14. Pregnancy
15. Uncontrolled epilepsy
16. Poor skin condition or those allergic to wipes of adhesive tape
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Spasticity,Cognitive status,Grip strength,Pinch strength,Hand function,Co-activation, muscle activation,Disability,Fine motor skills,Finger dexterity   Outcome measures will be evaluated at baseline, 6th and at the end of 12th week of intervention 
 
Secondary Outcome  
Outcome  TimePoints 
Stroke Motor Recovery Scale,Disability,Recovery of Motor Impairment,Disability,Lifestyle after stroke  Outcome measures will be evaluated at baseline, 6th and at the end of 12th week of intervention 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   22/07/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  22/07/2024 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="15" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Not published 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Stroke patients who met the inclusion and exclusion criteria will be selected for the study and will then be asked to sign a consent form. After signing the informed consent, stroke patients will be assigned to experimental and control group. Baseline measurement including Mini mental state examination (MMSE), demographic data etc. will be done to allow for more in-depth description of the participant’s impairment. The experimental group will receive the developed intervention and control group will receive conventional physiotherapy. All outcome measures will be recorded at the baseline assessment, and after every two week of intervention and at the end on completion of intervention.

Randomization will be performed using computer generated randomization table with a 1:1 ratio by a statistician not involved in the study. Subjects will be blinded to the groups will be allocated to Neuro-rehabilitation strategies group (Experimental Group) and conventional intervention group (Control Group). Group allocations will be assigned through sealed opaque envelopes. The envelopes will be kept in a closet by independent researcher who are not involved in the study.

Experimental group will receive developed neurorehabilitation strategies and conventional physiotherapy that will be given to control group includes range of motion, stretching and strengthening exercises of upper limb.

The duration of the study will be 12 weeks as most of the improvement in hand function occurs in between 8 weeks to 32 week. The dosage will be 45 mins, 5 days per week, at 50-80 % of maximum Heart Rate. This 45 mins session will include 5-10 min of warm-up and cool-down. 

Outcome measures will be evaluated at baseline, 6th and at the end of 12th week of intervention

 
Close